Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-040460
Filing Date
2007-02-27
Accepted
2007-02-27 08:27:30
Documents
10
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 ADOLOR CORPORATION - FORM 10-K d10k.htm 10-K 902191
2 AMENDED AND RESTATED 1994 EQUITY COMPENSATION PLAN dex101.htm EX-10.1 70047
3 FORM OF DEFERRED STOCK AWARD dex1030.htm EX-10.30 9914
4 INCENTIVE COMPENSATION PLAN dex1031.htm EX-10.31 11582
5 CONSENT OF KPMG LLP dex231.htm EX-23.1 2924
6 SECTION 302 CERTIFICATION OF CEO dex311.htm EX-31.1 8807
7 SECTION 302 CERTIFICATON OF CFO dex312.htm EX-31.2 8775
8 SECTION 906 CERTIFICATION OF CEO dex321.htm EX-32.1 2602
9 SECTION 906 CERTIFICATION OF CFO dex322.htm EX-32.2 2629
10 GRAPHIC g28302g13i03.jpg GRAPHIC 96474
  Complete submission text file 0001193125-07-040460.txt   1153847
Mailing Address 700 PENNSYLVANIA DRIVE EXTON PA 19341
Business Address 700 PENNSYLVANIA DRIVE EXTON PA 19341
ADOLOR CORP (Filer) CIK: 0001076167 (see all company filings)

EIN.: 311429198 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30039 | Film No.: 07651303
SIC: 2834 Pharmaceutical Preparations